Section of Medical Oncology

Research output

Research output per year 1975 2012 2013 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

• 3035 Article
• 479 Review article
• 146 Letter
• 143 Comment/debate
• 152 More
  • 67 Editorial
  • 59 Chapter
  • 19 Short survey
  • 4 Conference contribution
  • 1 Book
  • 1 Foreword/postscript
  • 1 Conference article

Research output per year

Research output per year

Search results

• 2018

  Mentoring

  Kahl, B. S., Apr 2018, In: Clinical Advances in Hematology and Oncology. 16, 4, p. 234 1 p.

  Research output: Contribution to journal › Letter › peer-review

• More CRO fun

  Kahl, B. S., May 2018, In: Clinical Advances in Hematology and Oncology. 16, 5, p. 304 1 p.

  Research output: Contribution to journal › Letter › peer-review

• Narcissist-in-chief

  Kahl, B. S., Feb 2018, In: Clinical Advances in Hematology and Oncology. 16, 2, p. 74 1 p.

  Research output: Contribution to journal › Letter › peer-review

• On relevance

  Kahl, B. S., Oct 2018, In: Clinical Advances in Hematology and Oncology. 16, 10, p. 634 1 p.

  Research output: Contribution to journal › Letter › peer-review

• Progressive multi-focal leucoencephalopathy among ibrutinib-treated persons with chronic lymphocytic leukaemia

  Bennett, C. L., Berger, J. R., Sartor, O., Carson, K. R., Hrushesky, W. J., Georgantopoulos, P., Raisch, D. W., Norris, L. A. B. & Armitage, J. O., Jan 2018, In: British Journal of Haematology. 180, 2, p. 301-304 4 p.

  Research output: Contribution to journal › Letter › peer-review

  Open Access
  10 Scopus citations

• The fast-changing world of CLL

  Kahl, B. S., Jun 2018, In: Clinical Advances in Hematology and Oncology. 16, 6, p. 396 1 p.

  Research output: Contribution to journal › Letter › peer-review

• Trivia night

  Kahl, B. S., Mar 2018, In: Clinical Advances in Hematology and Oncology. 16, 3, p. 159 1 p.

  Research output: Contribution to journal › Letter › peer-review

• With a little help from my friends

  Kahl, B. S., Dec 2018, In: Clinical Advances in Hematology and Oncology. 16, 12, p. 776 1 p.

  Research output: Contribution to journal › Letter › peer-review

• β-III-spectrin immunohistochemistry as a potential diagnostic tool with high sensitivity for malignant peripheral nerve sheath tumors

  Hirbe, A. C., Zhang, X., Dahiya, S., Godec, A., Chrisinger, J., Tao, Y., Luo, J. & Gutmann, D. H., May 18 2018, In: Neuro-oncology. 20, 6, p. 858-862 5 p.

  Research output: Contribution to journal › Letter › peer-review

  Open Access
  8 Scopus citations
• 2017

  9p24 abnormalities in hematologic malignancies with a focus on diffuse large B-cell lymphoma

  Patel, D. A., Hahn, A. W. & Martin, M. G., May 1 2017, In: Medical Oncology. 34, 5, 95.

  Research output: Contribution to journal › Letter › peer-review

• Affordable care?

  Kahl, B. S., Apr 2017, In: Clinical Advances in Hematology and Oncology. 15, 4, p. 227 1 p.

  Research output: Contribution to journal › Letter › peer-review

• ASCO cage match: BR vs R-CHOP

  Kahl, B. S., Jul 2017, In: Clinical Advances in Hematology and Oncology. 15, 7, p. 502 1 p.

  Research output: Contribution to journal › Letter › peer-review

• Book club: The Panama canal

  Kahl, B. S., Sep 2017, In: Clinical Advances in Hematology and Oncology. 15, 9, p. 651 1 p.

  Research output: Contribution to journal › Letter › peer-review

• Buyer beware!

  Kahl, B. S., May 2017, In: Clinical Advances in Hematology and Oncology. 15, 5, p. 318 1 p.

  Research output: Contribution to journal › Letter › peer-review

• Efficacy and safety of idelalisib in patients with relapsed, rituximab- and alkylating agent-refractory follicular lymphoma: A subgroup analysis of a phase 2 study

  Salles, G., Schuster, S. J., De Vos, S., Wagner-Johnston, N. D., Viardot, A., Blum, K. A., Flowers, C. R., Jurczak, W. J., Flinn, I. W., Kahl, B. S., Martin, P., Kim, Y., Shreay, S., Will, M., Sorensen, B., Breuleux, M., Zinzani, P. L. & Gopal, A. K., Mar 31 2017, In: Haematologica. 102, 4, p. e156-e159

  Research output: Contribution to journal › Letter › peer-review

  Open Access
  65 Scopus citations

• How to treat Hodgkin lymphoma

  Kahl, B. S., Oct 2017, In: Clinical Advances in Hematology and Oncology. 15, 10, p. 722 1 p.

  Research output: Contribution to journal › Letter › peer-review

• In memory of Oliver press, MD. PhD

  Kahl, B. S., Nov 2017, In: Clinical Advances in Hematology and Oncology. 15, 11, p. 806 1 p.

  Research output: Contribution to journal › Letter › peer-review

• Mantle cell lymphoma initial therapy with abbreviated R-CHOP followed by ⁹⁰Y-ibritumomab tiuxetan: 10-year follow-up of the phase 2 ECOG-ACRIN study E1499

  Smith, M. R., Hong, F., Li, H., Gordon, L. I., Gascoyne, R. D., Paietta, E. M., Advani, R. H., Forero-Torres, A., Horning, S. J. & Kahl, B. S., Feb 1 2017, In: Leukemia. 31, 2, p. 517-519 3 p.

  Research output: Contribution to journal › Letter › peer-review
  14 Scopus citations

• NR4A1 inhibition synergizes with ibrutinib in killing mantle cell lymphoma cells

  Li, Y., Wang, F., Lu, L., Zhu, F., Huang, S., Nomie, K., Zhang, L., Yang, D. T., Huang, W., Kahl, B. S., Safe, S., Wang, M. & Rui, L., Dec 1 2017, In: Blood cancer journal. 7, 12, 32.

  Research output: Contribution to journal › Letter › peer-review

  Open Access
  3 Scopus citations

• Protests

  Kahl, B. S., Dec 2017, In: Clinical Advances in Hematology and Oncology. 15, 12, p. 892 1 p.

  Research output: Contribution to journal › Letter › peer-review

• Reply to C.D. woodrell et al

  Sanoff, H. K., Chang, Y. & Reimers, M., Jun 1 2017, In: Journal of Oncology Practice. 13, 6, p. 406 1 p.

  Research output: Contribution to journal › Letter › peer-review

  Open Access

• Single institution experience with G-CSF mobilized T-cell replete haploidentical hematopoietic cell transplantation

  Huselton, E., Slade, M., Dipersio, J. F., Westervelt, P., Vij, R., Uy, G. L., Fehniger, T. A., Abboud, C. N., Gao, F., Schroeder, M. A. & Romee, R., May 1 2017, In: Bone Marrow Transplantation. 52, 5, p. 769-771 3 p.

  Research output: Contribution to journal › Letter › peer-review

  Open Access
  3 Scopus citations

• Take back the research

  Kahl, B. S., Aug 2017, In: Clinical Advances in Hematology and Oncology. 15, 8, p. 567 1 p.

  Research output: Contribution to journal › Letter › peer-review

• The ASH rehash

  Kahl, B. S., Jan 2017, In: Clinical Advances in Hematology and Oncology. 15, 1, p. 7 1 p.

  Research output: Contribution to journal › Letter › peer-review

• The impact of diabetes mellitus and other comorbidities on hematopoietic stem cell collection and hematologic recovery post-transplantation

  Fiala, M. A., Slade, M., Wang, S., Park, S., DiPersio, J. & Stockerl-Goldstein, K., Jan 2 2017, In: Leukemia and Lymphoma. 58, 1, p. 241-243 3 p.

  Research output: Contribution to journal › Letter › peer-review

• Untreated donor specific antibodies against HLA are associated with poor outcomes in peripheral blood haploidentical hematopoietic cell transplantation

  Zou, J., Romee, R., Slade, M., Phelan, D., Keller, J., Mohanakumar, T. & Grossman, B. J., Jun 1 2017, In: Bone Marrow Transplantation. 52, 6, p. 898-901 4 p.

  Research output: Contribution to journal › Letter › peer-review
  16 Scopus citations

• When will we beat R-CHOP?

  Kahl, B. S., Mar 2017, In: Clinical Advances in Hematology and Oncology. 15, 3, p. 159 1 p.

  Research output: Contribution to journal › Letter › peer-review
• 2016

  A phase I study of thymoglobulin for relapsed or refractory multiple myeloma

  Keller, J., Fiala, M. A., Dipersio, J., Stockerl-Goldstein, K., Vij, R. & Heldermon, C. D., Feb 1 2016, In: Leukemia and Lymphoma. 57, 2, p. 453-455 3 p.

  Research output: Contribution to journal › Letter › peer-review

• Clinical improvement with JAK2 inhibition in chuvash polycythemia

  Zhou, A. W., Knoche, E. M., Engle, E. K., Ban-Hoefen, M., Kaiwar, C. & Oh, S. T., Aug 4 2016, In: New England Journal of Medicine. 375, 5, p. 494-496 3 p.

  Research output: Contribution to journal › Letter › peer-review

  Open Access
  9 Scopus citations

• Cytomegalovirus viremia, disease, and impact on relapse in T-cell replete peripheral blood haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide

  Goldsmith, S. R., Slade, M., Dipersio, J. F., Westervelt, P., Lawrence, S. J., Uy, G. L., Abboud, C. N., Vij, R., Schroeder, M. A., Fehniger, T. A., Dubberke, E. R., Trinkaus, K. & Romee, R., Oct 31 2016, In: Haematologica. 101, 11, p. e465-e468

  Research output: Contribution to journal › Letter › peer-review

  Open Access
  49 Scopus citations

• Outcomes with R-CEOP for R-CHOP-ineligible patients with diffuse large B-cell lymphoma are highly dependent on cell of origin defined by Hans criteria

  Rashidi, A., Oak, E., Carson, K. R., Wagner-Johnston, N. D., Kreisel, F. & Bartlett, N. L., May 3 2016, In: Leukemia and Lymphoma. 57, 5, p. 1191-1193 3 p.

  Research output: Contribution to journal › Letter › peer-review
  19 Scopus citations
• 2015

  A multidisciplinary approach in neurofibromatosis 1-Authors' reply

  Epstein, J. A., Ingram, D. A., Hirbe, A. C. & Gutmann, D. H., Jan 1 2015, In: The Lancet Neurology. 14, 1, p. 30-31 2 p.

  Research output: Contribution to journal › Letter › peer-review

  Open Access
  2 Scopus citations

• BRCA2-associated pancreatic cancer and current screening guidelines

  Kasi, P. M., Pedersen, K. S. & McWilliams, R. R., Sep 1 2015, In: Cancer. 121, 17, p. 3046 1 p.

  Research output: Contribution to journal › Letter › peer-review

  Open Access
  3 Scopus citations

• Development and testing of a tool to assess patient preferences for phase i clinical trial participation

  Pentz, R. D., Hendershot, K. A., Wall, L., White, T. E., Peterson, S. K., Thomas, C. B., McCormick, J., Green, M. J., Lewis, C., Farmer, Z. L., Hlubocky, F. J., Dossul, T., Dixon, M. D., Liu, Y., Switchenko, J. M., Salvador, C., Owonikoko, T. K., Harvey, R. D. & Khuri, F. R., Jul 1 2015, In: Psycho-Oncology. 24, 7, p. 835-838 4 p.

  Research output: Contribution to journal › Letter › peer-review

  Open Access
  6 Scopus citations

• Maintenance rituximab every 2 months is more toxic than every 3 months in patients with non-Hodgkin lymphoma

  Rashidi, A., Oak, E. & Bartlett, N. L., 2015, In: Blood. 125, 21, p. 3354-3355 2 p.

  Research output: Contribution to journal › Letter › peer-review

  Open Access
  10 Scopus citations

• MET mutation associated with responsiveness to crizotinib

  Waqar, S. N., Morgensztern, D. & Sehn, J., May 30 2015, In: Journal of Thoracic Oncology. 10, 5, p. e29-e31

  Research output: Contribution to journal › Letter › peer-review

  Open Access
  78 Scopus citations

• Reply to C. Le Péchoux et al and B.S. Gill et al

  Robinson, C. G., Patel, A. P., DeWees, T., Morgensztern, D., Bradley, J. D. & Puri, V., Sep 10 2015, In: Journal of Clinical Oncology. 33, 26, p. 2932-2933 2 p.

  Research output: Contribution to journal › Letter › peer-review
  1 Scopus citations

• Reply to differences in 25-hydroxyvitamin D concentrations may explain most of the black-white breast cancer disparities noted in young women

  Ademuyiwa, F. O., Jun 1 2015, In: Cancer. 121, 12, p. 2098 1 p.

  Research output: Contribution to journal › Letter › peer-review

  Open Access

• Response to "Is post-operative radiotherapy of any benefit after R0 resection for N2 disease?"

  Robinson, C. G., Patel, A. P., DeWees, T., Morgensztern, D., Bradley, J. D. & Puri, V., 2015, In: Translational Lung Cancer Research. 4, 5, p. 667 1 p.

  Research output: Contribution to journal › Letter › peer-review
  1 Scopus citations

• RTOG 0522: Huge investment in patients and resources and no benefit with addition of cetuximab to radiotherapy-why did this occur?

  Adkins, D., Ley, J., Wildes, T. M. & Michel, L., Apr 1 2015, In: Journal of Clinical Oncology. 33, 10, p. 1223 1 p.

  Research output: Contribution to journal › Letter › peer-review

  Open Access
  6 Scopus citations
• 2014

  BRAF^V600E mutation in sporadic and neurofibromatosis type 1-related malignant peripheral nerve sheath tumors

  Hirbe, A. C., Pekmezci, M., Dahiya, S., Apicelli, A. J., Van Tine, B. A., Perry, A. & Gutmann, D. H., Mar 2014, In: Neuro-oncology. 16, 3, p. 466-467 2 p.

  Research output: Contribution to journal › Letter › peer-review

  Open Access
  32 Scopus citations

• Haploidentical transplantation using G-CSF-mobilized T-cell replete PBSCs and post-transplantation CY after non-myeloablative conditioning is safe and is associated with favorable outcomes

  Bhamidipati, P. K., Dipersio, J. F., Stokerl-Goldstein, K., Rashidi, A., Gao, F., Uy, G. L., Westervelt, P., Vij, R., Schroeder, M. A., Abboud, C. N., Keller, J. W., Fehniger, T. A. & Romee, R., Aug 2014, In: Bone Marrow Transplantation. 49, 8, p. 1124-1126 3 p.

  Research output: Contribution to journal › Letter › peer-review
  21 Scopus citations

• Infusion of cryopreserved autologous lymphocytes using a standard peripheral i.v. catheter

  Gladstone, D. E., Davis-Sproul, J., Campian, J., Lemas, M. V., Malatyali, S., Borrello, I., King, K. & Grossman, S. A., Aug 2014, In: Bone Marrow Transplantation. 49, 8, p. 1119-1120 2 p.

  Research output: Contribution to journal › Letter › peer-review

  Open Access
  1 Scopus citations

• Reply to magnetic resonance imaging-based diagnosis of progressive multifocal leukoencephalopathy in a patient with non-hodgkin lymphoma after therapy with cyclophosphamide, doxorubicin, vincristine, prednisone, and rituximab

  Bennett, C. L., Newsome, S. D. & Carson, K. R., Dec 1 2014, In: Cancer. 120, 24, p. 4006-4007 2 p.

  Research output: Contribution to journal › Letter › peer-review

  Open Access
  1 Scopus citations

• Response to: 'Pre-medications for cetuximab induced infusion reactions-Commentary'

  Adkins, D. & Ley, J., Dec 1 2014, In: Oral Oncology. 50, 12, p. e72

  Research output: Contribution to journal › Letter › peer-review

• Technical difficulties and evaluating e-Health interventions

  Semenkovich, N. P., Feb 2014, In: JAMA Internal Medicine. 174, 2, p. 304 1 p.

  Research output: Contribution to journal › Letter › peer-review
  3 Scopus citations
• 2013

  Decitabine in patients with relapsed acute myeloid leukemia (AML) after allogeneic stem cell transplantation (allo-SCT)

  Ganguly, S., Amin, M., Divine, C., Aljitawi, O. S., Abhyankar, S. & McGuirk, J. P., Apr 1 2013, In: Annals of Hematology. 92, 4, p. 549-550 2 p.

  Research output: Contribution to journal › Letter › peer-review
  25 Scopus citations

• Spectrum of EGFR mutation in lung adenocarcinoma in Morocco (3)

  Barraclough, H., Simms, L. & Govindan, R., 2013, In: Journal of Thoracic Oncology. 8, 12, p. e116-e117

  Research output: Contribution to journal › Letter › peer-review

  Open Access

• The era of big trials is over

  Rooney, M. & Govindan, R., Jan 2013, In: The Lancet Oncology. 14, 1, p. 12-14 3 p.

  Research output: Contribution to journal › Letter › peer-review
  1 Scopus citations

• Therapy in primary mediastinal B-cell lymphoma [4]

  Cashen, A., Christian, B. A. & Bartlett, N., Jul 26 2013, In: New England Journal of Medicine. 369, 3, p. 282-283 2 p.

  Research output: Contribution to journal › Letter › peer-review
  37 Scopus citations